Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects
Clinical trial NCT05172622 · UNKNOWN
Trial details
- NCT number
- NCT05172622
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2022-08-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.